Jorge Villacian

Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts

Li Yang Hsu, Cheng-Chuan Lee, Justin A. Green et al. · Emerging infectious diseases · 2003 · 286 citations · Full text

Veterinary Medicine, Infectious Diseases, Emerging Infectious Diseases +14

The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.

David H. Dockrell, Andrew D. Badley, Jorge Villacian et al. · Journal of Clinical Investigation · 1998 · 138 citations · Full text

Life Sciences, Immunology, Pathology +17

Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial

Pedro Cahn, Jorge Villacian, Adriano Lazzarin et al. · Clinical Infectious Diseases · 2006 · 81 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

Nicholas I. Paton, James F. Rooney, Wendy Snowden et al. · The Lancet HIV · 2017 · 80 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens

Jorge Villacian, Natalia Zahonero, Theresa Pattery et al. · Antimicrobial Agents and Chemotherapy · 2012 · 65 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17